Showing results (151-160 of 203) with videos related to

Sort By:
Pageof 21
Medrxiv : the Preprint Server for Health Sciences|February 26, 2024
Host-Microbe Multiomic Profiling Reveals Age-Dependent COVID-19 ImmunopathologyHoang Van Phan, Alexandra Tsitsiklis, Cole P Maguire, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2022
mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 Omicron variantVenkata-Viswanadh Edara, Kelly E Manning, Madison Ellis, et al.
Open Forum Infectious Diseases|July 23, 2015
First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090)Jonathan D Fuchs, Ian Frank, Marnie L Elizaga, et al.
Vaccine|January 5, 2025
Anti-neuraminidase and anti-hemagglutinin stalk responses to different influenza a(H7N9) vaccine regimensHana M El Sahly, Evan J Anderson, Lisa A Jackson, et al.
Research Square|May 13, 2022
Safety and Immunogenicity of a Third Dose of SARS-CoV-2 mRNA Vaccine - An Interim AnalysisEvan Anderson, Lisa Jackson, Nadine Rouphael, et al.
Vaccine|February 23, 2026
Impact of prior SARS-CoV-2 acquisition on binding and neutralizing antibody responses following COVID-19 vaccination: A cross-protocol analysis of individual-level data from six phase 3 clinical trialsAaron Hudson, Scott Borgetti, Anne-Marie Rick, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 10, 2024
COVID-19 Vaccine Efficacy in Participants With Weakened Immune Systems From 4 Randomized Controlled TrialsAmy C Sherman, Jessica Tuan, Valeria D Cantos, et al.
Cell Host & Microbe|April 2, 2021
Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variantVenkata Viswanadh Edara, Carson Norwood, Katharine Floyd, et al.
JAMA Network Open|May 28, 2025
Evaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial Data: A Secondary Cross-Protocol Analysis of 5 Randomized Clinical TrialsLeah I B Andrews, M Elizabeth Halloran, Kathleen M Neuzil, et al.
The New England Journal of Medicine|December 30, 2020
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 VaccineLindsey R Baden, Hana M El Sahly, Brandon Essink, et al.
Pageof 21